Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 213


Long-acting bronchodilator use after hospitalization for COPD: an observational study of health insurance claims data.

Baker CL, Zou KH, Su J.

Int J Chron Obstruct Pulmon Dis. 2014 May 3;9:431-9. doi: 10.2147/COPD.S59322. eCollection 2014.


Characteristics of patients with COPD newly prescribed a long-acting bronchodilator: a retrospective cohort study.

Wurst KE, St Laurent S, Mullerova H, Davis KJ.

Int J Chron Obstruct Pulmon Dis. 2014 Sep 25;9:1021-31. doi: 10.2147/COPD.S58258. eCollection 2014.


Variation in adherence with Global Initiative for Chronic Obstructive Lung Disease (GOLD) drug therapy guidelines: a retrospective actuarial claims data analysis.

Fitch K, Iwasaki K, Pyenson B, Plauschinat C, Zhang J.

Curr Med Res Opin. 2011 Jul;27(7):1425-9. doi: 10.1185/03007995.2011.583230. Epub 2011 May 23.


Adherence to current guidelines for chronic obstructive pulmonary disease (COPD) among patients treated with combination of long-acting bronchodilators or inhaled corticosteroids.

Asche CV, Leader S, Plauschinat C, Raparla S, Yan M, Ye X, Young D.

Int J Chron Obstruct Pulmon Dis. 2012;7:201-9. doi: 10.2147/COPD.S25805. Epub 2012 Mar 15.


Management of COPD in the UK primary-care setting: an analysis of real-life prescribing patterns.

Price D, West D, Brusselle G, Gruffydd-Jones K, Jones R, Miravitlles M, Rossi A, Hutton C, Ashton VL, Stewart R, Bichel K.

Int J Chron Obstruct Pulmon Dis. 2014 Aug 27;9:889-904. doi: 10.2147/COPD.S62750. eCollection 2014.


Burden of chronic obstructive pulmonary disease in Medicare beneficiaries residing in long-term care facilities.

Simoni-Wastila L, Blanchette CM, Qian J, Yang HW, Zhao L, Zuckerman IH, Pak GH, Silver H, Dalal AA.

Am J Geriatr Pharmacother. 2009 Oct;7(5):262-70. doi: 10.1016/j.amjopharm.2009.11.003.


Barriers to adherence to chronic obstructive pulmonary disease guidelines by primary care physicians.

Salinas GD, Williamson JC, Kalhan R, Thomashow B, Scheckermann JL, Walsh J, Abdolrasulnia M, Foster JA.

Int J Chron Obstruct Pulmon Dis. 2011;6:171-9. doi: 10.2147/COPD.S16396. Epub 2011 Feb 28.


Treatment patterns of chronic obstructive pulmonary disease in employed adults in the United States.

Diette GB, Dalal AA, D'Souza AO, Lunacsek OE, Nagar SP.

Int J Chron Obstruct Pulmon Dis. 2015 Feb 24;10:415-22. doi: 10.2147/COPD.S75034. eCollection 2015.


Indacaterol therapy in moderate-to-severe chronic obstructive pulmonary disease: findings from a single-center primary care cohort.

Singh MP.

Int J Chron Obstruct Pulmon Dis. 2013;8:613-9. doi: 10.2147/COPD.S53707. Epub 2013 Dec 9.


Respiratory-related medical expenditure and inpatient utilisation among COPD patients receiving long-acting bronchodilator therapy.

Cao Z, Zou KH, Baker CL, Su J, Paulose-Ram R, Durden E, Shi N, Shah H.

J Med Econ. 2011;14(2):147-58. doi: 10.3111/13696998.2011.552582. Epub 2011 Feb 2.


Subutilization of COPD guidelines in primary care: a pilot study.

Laniado-Laborín R, Rendón A, Alcantar-Schramm JM, Cazares-Adame R, Bauerle O.

J Prim Care Community Health. 2013 Jul 1;4(3):172-6. doi: 10.1177/2150131913475817. Epub 2013 Jan 31.


Risk assessment of readmissions following an initial COPD-related hospitalization.

Baker CL, Zou KH, Su J.

Int J Chron Obstruct Pulmon Dis. 2013;8:551-9. doi: 10.2147/COPD.S51507. Epub 2013 Nov 12.


Diagnosis and management of chronic obstructive pulmonary disease (COPD) in a primary care clinic.

Chavez PC, Shokar NK.

COPD. 2009 Dec;6(6):446-51. doi: 10.3109/15412550903341455.


Comparative cost-effectiveness of a fluticasone-propionate/salmeterol combination versus anticholinergics as initial maintenance therapy for chronic obstructive pulmonary disease.

Dalal AA, Roberts MH, Petersen HV, Blanchette CM, Mapel DW.

Int J Chron Obstruct Pulmon Dis. 2010 Dec 31;6:13-22. doi: 10.2147/COPD.S15455.


Determinants of polypharmacy and compliance with GOLD guidelines in patients with chronic obstructive pulmonary disease.

Franssen FM, Spruit MA, Wouters EF.

Int J Chron Obstruct Pulmon Dis. 2011;6:493-501. doi: 10.2147/COPD.S24443. Epub 2011 Sep 26.


Use and outcomes associated with long-acting bronchodilators among patients hospitalized for chronic obstructive pulmonary disease.

Lindenauer PK, Shieh MS, Pekow PS, Stefan MS.

Ann Am Thorac Soc. 2014 Oct;11(8):1186-94. doi: 10.1513/AnnalsATS.201407-311OC.


Hospital readmissions following initiation of nebulized arformoterol tartrate or nebulized short-acting beta-agonists among inpatients treated for COPD.

Bollu V, Ernst FR, Karafilidis J, Rajagopalan K, Robinson SB, Braman SS.

Int J Chron Obstruct Pulmon Dis. 2013;8:631-9. doi: 10.2147/COPD.S52557. Epub 2013 Dec 5.

Items per page

Supplemental Content

Write to the Help Desk